Skip to main content
Erschienen in: Cancer Causes & Control 1/2013

01.01.2013 | Original paper

Prostate cancer incidence and tumor severity in Georgia: descriptive epidemiology, racial disparity, and geographic trends

verfasst von: Sara E. Wagner, Sarah E. Bauer, A. Rana Bayakly, John E. Vena

Erschienen in: Cancer Causes & Control | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Limited research has been conducted to describe the geographical clustering and distribution of prostate cancer (PrCA) incidence in Georgia (GA). This study describes and compares the temporal and geographic trends of PrCA incidence in GA with a specific focus on racial disparities.

Methods

GA Comprehensive Cancer Registry PrCA incidence data were obtained for 1998–2008. Directly standardized age-adjusted PrCA incidence rates per 100,000 were analyzed by race, stage, grade, and county. County-level hotspots of PrCA incidence were analyzed with the Getis-Ord Gi* statistic in a geographic information system; a census tract-level cluster analysis was performed with a Discrete Poisson model and implemented in SaTScan® software.

Results

Significant (p < 0.05) hotspots of PrCA incidence were observed in nine southwestern counties and six centrally located counties among men of both races. Six significant (p < 0.1) clusters of PrCA incidence rates were detected for men of both races in north and northwest central Georgia. When stratified by race, clusters among white and black men were similar, although centroids were slightly shifted. Most notably, a large (122 km radius) cluster in northwest central Georgia was detected only in whites, and two smaller clusters (0–32 km radii) were detected in Southwest Georgia only in black men. Clusters of high-grade and late-stage tumors were identified primarily in the northern portion of the state among men of both races.

Conclusions

This study revealed a pattern of higher incidence and more advanced disease in northern and northwest central Georgia, highlighting geographic patterns that need more research and investigation of possible environmental determinants.
Literatur
3.
Zurück zum Zitat McNamara C, Davis V, Bayakly AR, Moon T (2010) Prostate cancer in Georgia, 2002–2006. Georgia Department of Community Health, Division of Public Health, Chronic Disease, Healthy Behaviors, and Injury Epidemiology McNamara C, Davis V, Bayakly AR, Moon T (2010) Prostate cancer in Georgia, 2002–2006. Georgia Department of Community Health, Division of Public Health, Chronic Disease, Healthy Behaviors, and Injury Epidemiology
4.
Zurück zum Zitat Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV (2006) Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc 102:241–249PubMed Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV (2006) Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc 102:241–249PubMed
6.
Zurück zum Zitat Wagner SE, Hurley DM, Hebert J, McNamara C, Bayakly AR, Vena JE (2012) Cancer mortality-to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants. Cancer 118(16):4032–4045 Wagner SE, Hurley DM, Hebert J, McNamara C, Bayakly AR, Vena JE (2012) Cancer mortality-to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants. Cancer 118(16):4032–4045
7.
Zurück zum Zitat Steenland K, Goodman M, Liff J, Diiorio C, Butler S, Roberts P, et al (2011) The effect of race and rural residence on prostate cancer treatment choice among men in Georgia. Urology 77(3):581–587 Steenland K, Goodman M, Liff J, Diiorio C, Butler S, Roberts P, et al (2011) The effect of race and rural residence on prostate cancer treatment choice among men in Georgia. Urology 77(3):581–587
8.
Zurück zum Zitat DiIorio C, Steenland K, Goodman M, Butler S, Liff J, Roberts P (2011) Differences in treatment- based beliefs and coping between African American and white men with prostate cancer. J Commun Health 36(4): 505–512 DiIorio C, Steenland K, Goodman M, Butler S, Liff J, Roberts P (2011) Differences in treatment- based beliefs and coping between African American and white men with prostate cancer. J Commun Health 36(4): 505–512
9.
Zurück zum Zitat Butler S, Owen-Smith A, DiIorio C, Goodman M, Liff J, Steenland K (2011) Use of complementary and alternative medicine among men with prostate cancer in a rural setting. J Commun Health 36(6):1004–1010 Butler S, Owen-Smith A, DiIorio C, Goodman M, Liff J, Steenland K (2011) Use of complementary and alternative medicine among men with prostate cancer in a rural setting. J Commun Health 36(6):1004–1010
10.
Zurück zum Zitat Steenland K, Goodman M, Liff J, Diiorio C, Butler S, Roberts P (2011) Quality of life among men with prostate cancer in rural Georgia. Urology 77(4):927–933 Steenland K, Goodman M, Liff J, Diiorio C, Butler S, Roberts P (2011) Quality of life among men with prostate cancer in rural Georgia. Urology 77(4):927–933
11.
Zurück zum Zitat Lefevre ML (1998) Prostate cancer screening: more harm than good? Am Fam Physician 58(2):432–438PubMed Lefevre ML (1998) Prostate cancer screening: more harm than good? Am Fam Physician 58(2):432–438PubMed
12.
Zurück zum Zitat Kulldorff M (1997) A spatial scan statistic. Commun Stat Theory Methods 26:1481–1496CrossRef Kulldorff M (1997) A spatial scan statistic. Commun Stat Theory Methods 26:1481–1496CrossRef
13.
Zurück zum Zitat Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
14.
Zurück zum Zitat Catalona WJ, Smith DS, Ornstein DK (1997) Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 277:1452–1455PubMedCrossRef Catalona WJ, Smith DS, Ornstein DK (1997) Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 277:1452–1455PubMedCrossRef
15.
Zurück zum Zitat Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93(8):1139–1150PubMedCrossRef Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93(8):1139–1150PubMedCrossRef
16.
Zurück zum Zitat Lambert JD, Yang CS (2003) Mechanisms of cancer prevention by tea constituents. J Nutr 133(10):3262S–3267SPubMed Lambert JD, Yang CS (2003) Mechanisms of cancer prevention by tea constituents. J Nutr 133(10):3262S–3267SPubMed
17.
Zurück zum Zitat Nelson WG, DeWeese TL, DeMarzo AM (2002) The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 21:13–16CrossRef Nelson WG, DeWeese TL, DeMarzo AM (2002) The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 21:13–16CrossRef
18.
Zurück zum Zitat Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49(3):222–228PubMed Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49(3):222–228PubMed
19.
Zurück zum Zitat Sommer F, Klotz T, Schmitz-Drager BJ (2004) Lifestyle issues and genitourinary tumours. World J Urol 21(6):402–413PubMedCrossRef Sommer F, Klotz T, Schmitz-Drager BJ (2004) Lifestyle issues and genitourinary tumours. World J Urol 21(6):402–413PubMedCrossRef
20.
21.
Zurück zum Zitat Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92(4):237–253PubMedCrossRef Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92(4):237–253PubMedCrossRef
22.
Zurück zum Zitat Soronen P, Laiti M, Torn S, Harkonen P, Patrikainen L, Li Y et al (2004) Sex steroid hormone metabolism and prostate cancer. J Steroid Biochem Mol Biol 92(4):281–286PubMedCrossRef Soronen P, Laiti M, Torn S, Harkonen P, Patrikainen L, Li Y et al (2004) Sex steroid hormone metabolism and prostate cancer. J Steroid Biochem Mol Biol 92(4):281–286PubMedCrossRef
23.
Zurück zum Zitat Turesky RJ (2004) The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr Drug Metab 5(2):169–180PubMedCrossRef Turesky RJ (2004) The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr Drug Metab 5(2):169–180PubMedCrossRef
26.
Zurück zum Zitat 42 Code of Federal Regulations (CFR), Chapter 1, Part 5, Appendix A (October 1, 1993, pp. 34–48) Criteria for designation of areas having shortages of primary medical care professionals [45 FR 76000, Nov. 17, 1980, as amended at 54 FR 8737, Mar. 2, 1989; 57 FR 2480, Jan. 22, 1992] 42 Code of Federal Regulations (CFR), Chapter 1, Part 5, Appendix A (October 1, 1993, pp. 34–48) Criteria for designation of areas having shortages of primary medical care professionals [45 FR 76000, Nov. 17, 1980, as amended at 54 FR 8737, Mar. 2, 1989; 57 FR 2480, Jan. 22, 1992]
28.
Zurück zum Zitat Hartley D (2004) Rural health disparities, population health, and rural culture. Am J Public Health 94(10):1675–1678 Hartley D (2004) Rural health disparities, population health, and rural culture. Am J Public Health 94(10):1675–1678
29.
Zurück zum Zitat Bynum J, Song Y, Fisher E (2010) Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc 58(4):674–680PubMedCrossRef Bynum J, Song Y, Fisher E (2010) Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc 58(4):674–680PubMedCrossRef
30.
Zurück zum Zitat Smith RA, Cokkinides V, Brawley OW (2008) Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin 58:161–179PubMedCrossRef Smith RA, Cokkinides V, Brawley OW (2008) Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin 58:161–179PubMedCrossRef
31.
Zurück zum Zitat US Preventive Services Task Force (2011) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149:185–191 US Preventive Services Task Force (2011) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149:185–191
32.
Zurück zum Zitat Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360:13CrossRef Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360:13CrossRef
33.
Zurück zum Zitat Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schroder FH, Vickers AJ (2012) Risk- based prostate cancer screening. Eur Urol 61(4):652–661PubMedCrossRef Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schroder FH, Vickers AJ (2012) Risk- based prostate cancer screening. Eur Urol 61(4):652–661PubMedCrossRef
34.
Zurück zum Zitat Greenberg RS, Stevens JA, Whitaker JP (1985) Cancer incidence aong blacks in urban and rural Georgia, 1978–1982. Am J Public Health 75:683–684PubMedCrossRef Greenberg RS, Stevens JA, Whitaker JP (1985) Cancer incidence aong blacks in urban and rural Georgia, 1978–1982. Am J Public Health 75:683–684PubMedCrossRef
35.
Zurück zum Zitat Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O’Brien KM, et al (2011) A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 22(3):341–357 Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O’Brien KM, et al (2011) A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control 22(3):341–357
36.
Zurück zum Zitat Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T et al (2002) American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 52(2):92–119 Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T et al (2002) American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 52(2):92–119
37.
Zurück zum Zitat Beebe-Dimer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA (2007) Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 109:875–881CrossRef Beebe-Dimer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA (2007) Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 109:875–881CrossRef
38.
Zurück zum Zitat Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG et al (1995) Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 60(3):361–364PubMedCrossRef Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG et al (1995) Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 60(3):361–364PubMedCrossRef
39.
Zurück zum Zitat Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, et al (2011) Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev 20(1):23–32 Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, et al (2011) Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev 20(1):23–32
40.
Zurück zum Zitat Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD (2007) African-American men’s perceptions about prostate cancer: implications for designing educational interventions. Soc Sci Med 64(11):2189–2200PubMedCrossRef Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD (2007) African-American men’s perceptions about prostate cancer: implications for designing educational interventions. Soc Sci Med 64(11):2189–2200PubMedCrossRef
41.
Zurück zum Zitat Glicksman AS, Meyer A, DiPiero M (2012) Tailored community cancer education programs: pawsox and prostates. J Cancer Educ 25(2):180–183CrossRef Glicksman AS, Meyer A, DiPiero M (2012) Tailored community cancer education programs: pawsox and prostates. J Cancer Educ 25(2):180–183CrossRef
46.
Zurück zum Zitat Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19(8):1893–1907 Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19(8):1893–1907
47.
Zurück zum Zitat Hsing AW, Tsao L, Devesa SS (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85(1):60–67PubMedCrossRef Hsing AW, Tsao L, Devesa SS (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85(1):60–67PubMedCrossRef
Metadaten
Titel
Prostate cancer incidence and tumor severity in Georgia: descriptive epidemiology, racial disparity, and geographic trends
verfasst von
Sara E. Wagner
Sarah E. Bauer
A. Rana Bayakly
John E. Vena
Publikationsdatum
01.01.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0101-0

Weitere Artikel der Ausgabe 1/2013

Cancer Causes & Control 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.